Toggle Main Menu Toggle Search

Open Access padlockePrints

Rare disease research workflow using multilayer networks elucidates the molecular determinants of severity in Congenital Myasthenic Syndromes

Lookup NU author(s): Dr Ana TopfORCiD

Downloads


Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).


Abstract

© The Author(s) 2024.Exploring the molecular basis of disease severity in rare disease scenarios is a challenging task provided the limitations on data availability. Causative genes have been described for Congenital Myasthenic Syndromes (CMS), a group of diverse minority neuromuscular junction (NMJ) disorders; yet a molecular explanation for the phenotypic severity differences remains unclear. Here, we present a workflow to explore the functional relationships between CMS causal genes and altered genes from each patient, based on multilayer network community detection analysis of complementary biomedical information provided by relevant data sources, namely protein-protein interactions, pathways and metabolomics. Our results show that CMS severity can be ascribed to the personalized impairment of extracellular matrix components and postsynaptic modulators of acetylcholine receptor (AChR) clustering. This work showcases how coupling multilayer network analysis with personalized -omics information provides molecular explanations to the varying severity of rare diseases; paving the way for sorting out similar cases in other rare diseases.


Publication metadata

Author(s): Nunez-Carpintero I, Rigau M, Bosio M, O'Connor E, Spendiff S, Azuma Y, Topf A, Thompson R, 't Hoen PAC, Chamova T, Tournev I, Guergueltcheva V, Laurie S, Beltran S, Capella-Gutierrez S, Cirillo D, Lochmuller H, Valencia A

Publication type: Article

Publication status: Published

Journal: Nature Communications

Year: 2024

Volume: 15

Issue: 1

Online publication date: 28/02/2024

Acceptance date: 15/01/2024

Date deposited: 11/03/2024

ISSN (electronic): 2041-1723

Publisher: Nature Research

URL: https://doi.org/10.1038/s41467-024-45099-0

DOI: 10.1038/s41467-024-45099-0

Data Access Statement: WGS metadata and variant data, and patient phenotypic descriptions have been deposited in the RD-Connect GPAP: https://platform.rd-connect.eu/#/. This data is available under controlled access for registered users of the GPAP. Details on access to GPAP can be found in: https://platform.rd-connect.eu/userregistration. [See remainder of Data availability statement at https://www.nature.com/articles/s41467-024-45099-0#data-availability https://www.nature.com/articles/s41467-024-45099-0#code-availability ]


Altmetrics

Altmetrics provided by Altmetric


Funding

Funder referenceFunder name
2012-305444
2012-305121
European Union
Seventh Framework Programme for research, technological development and demonstration

Share